Jan Vaage
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 14
- Oncology top 5%
- Cancer Cells and Metastasis 11
- Cancer-related Molecular Pathways 6
- Immunology top 10%
- Immunotherapy and Immune Responses 19
- Biotechnology top 5%
- Cancer Research and Treatments 13
-
- Virus-based gene therapy research 14
-
- RNA Interference and Gene Delivery 9
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- E. MayhewPeter K. WorkingPaul S. UsterR.M. AbraAnthony H. C. HuangWilliam J. LindbladFrank MartinD. D. Lasic
- Cited by
- BiomaterialsOncologyImmunology
- Journals
- International Journal of Cancer (12 papers)JNCI Journal of the National Cancer Institute (4 papers)Cancer (3 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Jan Vaage
71 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 98
- Biomaterials 493
- Oncology 680
- Immunology 409
- Biotechnology 149
- Cancer Research 140
Countries citing papers authored by Jan Vaage
This map shows the geographic impact of Jan Vaage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Vaage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Vaage more than expected).
Fields of papers citing papers by Jan Vaage
This network shows the impact of papers produced by Jan Vaage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Vaage. The network helps show where Jan Vaage may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Vaage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 40 | |
| 2 | 1998 | 1 | |
| 3 | 1997 | 89 | |
| 4 | 1995 | 11 | |
| 5 | 1994 | 133 | |
| 6 | 1993 | 57 | |
| 7 | 1992 | 8 | |
| 8 | 1992 | 16 | |
| 9 | 1991 | 20 | |
| 10 | 1991 | 24 | |
| 11 | 1991 | 1 | |
| 12 | 1991 | 14 | |
| 13 | 1989 | 5 | |
| 14 | 1989 | 5 | |
| 15 | A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas. | 1978 | 26 |
| 16 | Serum therapy for radiation-induced impairment of immune resistance to metastasis. | 1977 | 5 |
| 17 | Radiation-induced changes in established tumor immunity. | 1974 | 17 |
| 18 | Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice. | 1973 | 22 |
| 19 | Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice. | 1972 | 37 |
| 20 | Effect of immune status on the development of artificially induced metastases in different anatomical locations. | 1971 | 19 |
About Jan Vaage
Jan Vaage is a scholar working on Biotechnology, Oncology, Biomaterials, Immunology and Genetics, having authored 72 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (19 papers), Virus-based gene therapy research (14 papers), Nanoparticle-Based Drug Delivery (14 papers), Cancer Research and Treatments (13 papers), Cancer Cells and Metastasis (11 papers), RNA Interference and Gene Delivery (9 papers), Cancer-related Molecular Pathways (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Biomaterials (493 citations), Oncology (680 citations), Immunology (409 citations), Biotechnology (149 citations) and Cancer Research (140 citations). Jan Vaage has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include E. Mayhew, Peter K. Working, Paul S. Uster, R.M. Abra, Anthony H. C. Huang, William J. Lindblad, Frank Martin, D. D. Lasic, Emilio Barberá‐Guillem and S.K. Huang. Their work appears in journals such as International Journal of Cancer, JNCI Journal of the National Cancer Institute, Cancer, British Journal of Cancer and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.